Over the last decade a better understanding of the mechanism for immune disposal of hepatocytes infected with the Hepatitis C virus enabled the design of antiviral regimens with increasing efficacy. The poor rates of sustained viral clearance initially obtained with recombinant interferon (12%) have now improved to over 70 % with the use of a combination of pegylated interferon and the guanosine analogue ribavarine. The relatively poor response of genotype 1 strains to this regimen continues to challenge scientists and clinicians. This article reviews the theoretical and practical aspects of selection of patients for viral eradication, their management during treatment and subsequent follow-u
Recent discoveries of direct acting antivirals against Hepatitis C virus (HCV) have raised hopes of ...
Hepatitis C virus (HCV) infects around 71 million people worldwide and in 2018 it is still a major h...
People who inject drugs (PWID) represent the core of the hepatitis C virus (HCV) epidemic in many co...
Over the last decade a better understanding of the mechanism for immune disposal of hepatocytes infe...
Journal Article; Review;About 130-170 million people, is estimated to be infected with the hepatitis...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Pegylated interferon α (peginterferon α) plus ribavirin is the present mainstay of treatment for pat...
The treatment of chronic hepatitis C is a rapidly changing arena with new medications, new guideline...
Treatment of chronic hepatitis C is currently based on a combination of pegylated interferon-α and r...
Abstract The cloning of the genome of the Hepatitis C virus (HCV) in 1989 provided sensitive screeni...
Background: Therapeutic options for the management of hepatitis C virus (HCV) infection have evolved...
Opportunities to treat infection with hepatitis C virus (HCV) are evolving rapidly. From the introdu...
Pegylated interferon and ribavirin combination therapy is accepted as the standard antiviral treatme...
The hepatitis C virus now infects 170 million people worldwide. The majority of infected people deve...
Copyright © 2013 Hee Bok Chae et al. This is an open access article distributed under the Creative C...
Recent discoveries of direct acting antivirals against Hepatitis C virus (HCV) have raised hopes of ...
Hepatitis C virus (HCV) infects around 71 million people worldwide and in 2018 it is still a major h...
People who inject drugs (PWID) represent the core of the hepatitis C virus (HCV) epidemic in many co...
Over the last decade a better understanding of the mechanism for immune disposal of hepatocytes infe...
Journal Article; Review;About 130-170 million people, is estimated to be infected with the hepatitis...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Pegylated interferon α (peginterferon α) plus ribavirin is the present mainstay of treatment for pat...
The treatment of chronic hepatitis C is a rapidly changing arena with new medications, new guideline...
Treatment of chronic hepatitis C is currently based on a combination of pegylated interferon-α and r...
Abstract The cloning of the genome of the Hepatitis C virus (HCV) in 1989 provided sensitive screeni...
Background: Therapeutic options for the management of hepatitis C virus (HCV) infection have evolved...
Opportunities to treat infection with hepatitis C virus (HCV) are evolving rapidly. From the introdu...
Pegylated interferon and ribavirin combination therapy is accepted as the standard antiviral treatme...
The hepatitis C virus now infects 170 million people worldwide. The majority of infected people deve...
Copyright © 2013 Hee Bok Chae et al. This is an open access article distributed under the Creative C...
Recent discoveries of direct acting antivirals against Hepatitis C virus (HCV) have raised hopes of ...
Hepatitis C virus (HCV) infects around 71 million people worldwide and in 2018 it is still a major h...
People who inject drugs (PWID) represent the core of the hepatitis C virus (HCV) epidemic in many co...